Avenue Therapeutics Inc. (ATXI) at a glance

Avenue Therapeutics Inc. (ATXI) is a micro-cap Healthcare company. It trades at $0.32, with a P/E of 0.4 and a -124.8% profit margin. It does not pay a dividend. Vestovix scores it 63/100 overall. Its strongest dimension is Value (89/100) and its weakest is Momentum (28/100). It is a relatively defensive holding with below-market volatility.

Price
$0.32
Market cap
$1.1M
P/E ratio
0.4
Dividend yield
None
Beta
-0.17
52-week range
$0.15 to $0.97
Vestovix Score63/ 100How this works
Value
89
Growth
50
Income
40
Safety
86
Momentum
28